AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimven-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Anvicure Drugs

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimven-M1 Tablet SR

DiaBeta-Duo SR tablets are classified as antidiabetic agents, a combination medication for adult type 2 diabetes management. This dual-action formula helps regulate blood glucose. DiaBeta-Duo SR should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are key to effective diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and treat these symptoms; maintain regular meals and carry a fast-acting glucose source like candy or juice. Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your physician of any history of heart disease before commencing treatment, as DiaBeta-Duo SR may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to monitor blood cell counts and liver function.

Uses of Glimven-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimven-M1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimven-M1 Tablet SR should be administered with a meal.

Common Side effects of Glimven-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimven-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimven-M1 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

How Glimven-M1 Tablet SR works:

Glimven-M1 SR tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glimven-M1 Tablet SR is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimven-M1 tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimven-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glimven-M1 SR tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Glimven-M1 SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Glimven-M1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A low starting dose is usually recommended for individuals with mild to moderate liver disease; however, Glimven-M1 Tablet SR is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimven-M1 Tablet SR :

Should you forget a dose of Glimven-M1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimven-M1 Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimven-M1 Tablet SR

Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and other individuals.
Glimven-M1 Tablet SR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches, weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia warrant immediate discontinuation of Glimven-M1 Tablet SR and prompt medical attention.
Glimepiride and Metformin, combined as Glimven-M1 SR tablets, manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood sugar control when used with a suitable diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin reduces hepatic glucose output and increases insulin effectiveness. This dual-drug therapy is unsuitable for type 1 DM.
Glimven-M1 SR tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Less frequent, but more serious adverse reactions such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Glimven-M1 Tablet SR use can indeed lead to Vitamin B12 deficiency due to impaired intestinal absorption of the vitamin. This deficiency, if left unaddressed, may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Glimven-M1 Tablet SR can indeed induce hypoglycemia (low blood sugar). Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. Carrying a readily available source of glucose, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimven-M1 Tablet SR and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimven-M1 Tablet SR
37
MRP 45
17% off